Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Under the terms of the option agreement, which was signed in December 2024, Bausch + Lomb has secured the exclusive option to acquire InflammX Therapeutics during an agreed-upon option period based on ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in DME Published in peer-reviewed journal Translational ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.

LAS VEGAS and NEW YORK, Jan. 6, 2025 /PRNewswire/ -- SolidddVision™ smartglasses, the first true vision correction for people ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 ...